BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26686489)

  • 1. Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.
    Chauvet N; Romanò N; Meunier AC; Galibert E; Fontanaud P; Mathieu MN; Osterstock G; Osterstock P; Baccino E; Rigau V; Loiseau H; Bouillot-Eimer S; Barlier A; Mollard P; Coutry N
    J Neuroendocrinol; 2016 Feb; 28(2):12352. PubMed ID: 26686489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.
    Qian ZR; Li CC; Yamasaki H; Mizusawa N; Yoshimoto K; Yamada S; Tashiro T; Horiguchi H; Wakatsuki S; Hirokawa M; Sano T
    Mod Pathol; 2002 Dec; 15(12):1357-65. PubMed ID: 12481018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study.
    Mo C; Chen H; Xu J; Guo Y; Wang Y; Li Z; Tong T; Gui S; Zhong L
    Endocr Pract; 2024 May; 30(5):441-449. PubMed ID: 38307455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and significance of E-cadherin and β-catenins in pituitary adenoma.
    Zhou K; Jin H; Luo Y
    Int J Surg Pathol; 2013 Aug; 21(4):363-7. PubMed ID: 23349466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.
    Xu B; Sano T; Yoshimoto K; Yamada S
    Endocr Pathol; 2002; 13(4):341-51. PubMed ID: 12665652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
    Shimon I; Hinton DR; Weiss MH; Melmed S
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of somatotrophs, mammosomatotrophs, and mammotrophs by sandwich cell immunoblot assay in GH-secreting adenomas and prolactinomas: correlations between the proportions of hormone secreting cells and tumor size.
    Kojima Y; Suzuki S; Yamamura K; Kawasaki T; Yamamoto I
    Endocr J; 2000 Apr; 47(2):143-55. PubMed ID: 10943738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas.
    Elston MS; Gill AJ; Conaglen JV; Clarkson A; Cook RJ; Little NS; Robinson BG; Clifton-Bligh RJ; McDonald KL
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1436-42. PubMed ID: 19158195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.
    Obari A; Sano T; Ohyama K; Kudo E; Qian ZR; Yoneda A; Rayhan N; Mustafizur Rahman M; Yamada S
    Endocr Pathol; 2008; 19(2):82-91. PubMed ID: 18629656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
    Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
    Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly.
    Lekva T; Berg JP; Fougner SL; Olstad OK; Ueland T; Bollerslev J
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1506-14. PubMed ID: 22585092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas.
    Jin L; Riss D; Ruebel K; Kajita S; Scheithauer BW; Horvath E; Kovacs K; Lloyd RV
    Endocr Pathol; 2005; 16(2):107-14. PubMed ID: 16199895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.
    Mendes GA; Haag T; Trott G; Rech CGSL; Ferreira NP; Oliveira MC; Kohek MB; Pereira-Lima JFS
    Braz J Med Biol Res; 2017 Dec; 51(2):e6808. PubMed ID: 29267504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and analysis in 1385 Chinese patients with pituitary adenomas.
    Shao S; Li X
    J Neurosurg Sci; 2013 Sep; 57(3):267-75. PubMed ID: 23877272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of c-kit (CD117) expression in human normal pituitary cells and pituitary adenomas.
    La Rosa S; Uccella S; Dainese L; Marchet S; Placidi C; Vigetti D; Capella C
    Endocr Pathol; 2008; 19(2):104-11. PubMed ID: 18568298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas.
    Sano T; Rong QZ; Kagawa N; Yamada S
    Front Horm Res; 2004; 32():127-32. PubMed ID: 15281343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation.
    Lania AG; Ferrero S; Pivonello R; Mantovani G; Peverelli E; Di Sarno A; Beck-Peccoz P; Spada A; Colao A
    J Clin Endocrinol Metab; 2010 Jan; 95(1):13-7. PubMed ID: 19890024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.